Global Wet Age-Related Macular Degeneration Clinical Trial Pipeline Highlights 2019 – Forecast to 2024 – ResearchAndMarkets.com
June 4, 2019DUBLIN–(BUSINESS WIRE)–The “Global
Wet Age-Related Macular Degeneration Clinical Trial Pipeline Highlights
– 2019” report has been added to ResearchAndMarkets.com’s
offering.
Wet Age-Related Macular Degeneration Pipeline Highlights – 2019,
provides most up-to-date information on key pipeline products in the
global Wet Age-Related Macular Degeneration market. It covers emerging
therapies for Wet Age-Related Macular Degeneration in active clinical
development stages including early and late stage clinical trials. The
pipeline data presented in this report helps executives for tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.
Clinical Trial Stages:
The report provides Wet Age-Related Macular Degeneration pipeline
products by clinical trial stages including both early and late stage
development – phase 3 clinical trials, phase 2 clinical trials, phase 1
clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Wet Age-Related Macular Degeneration pipeline
products by their dominant mechanism of action/drug class. This helps
executives categorize products based on their drug class and also assess
the strengths and weaknesses of compounds.
Company:
The report provides Wet Age-Related Macular Degeneration pipeline
products by the company.
Short-term Launch Highlights:
Find out which Wet Age-Related Macular Degeneration pipeline products
will be launched in the US and Ex-US till 2024.
Summary:
-
Wet Age-Related Macular Degeneration phase 3 clinical trial pipeline
products -
Wet Age-Related Macular Degeneration phase 2 clinical trial pipeline
products -
Wet Age-Related Macular Degeneration phase 1 clinical trial pipeline
products -
Wet Age-Related Macular Degeneration preclinical research pipeline
products - Wet Age-Related Macular Degeneration discovery stage pipeline products
-
Wet Age-Related Macular Degeneration pipeline products short-term
launch highlights
For more information about this report visit https://www.researchandmarkets.com/r/9r1ugq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Optical
Disorders Drugs